| Pharmaceutical manufacturing industry is related to the people’s livelihood,is an important part of the national economy.At present,China’s pharmaceutical manufacturing industry is in a period of change and rapid development.With an aging population,increasing urbanization,and a gradually improving medical insurance system,people are paying more attention to their health,and the demand for related pharmaceutical products is gradually expanding.The goal of medical insurance cost control policy makers is to ensure that patients have timely access to affordable,safe and effective medicines.They also provide incentives for innovative research and development and industrial development of pharmaceutical products so that drugs can effectively meet the growing and changing demand for medicines.As well as developing measures to ensure the sustainability of medical insurance fund budgets by purchasing these drugs at prices affordable to medical insurance funds and consumers.The achievement of these goals requires a comprehensive balance of the interests of market players.So what is the mechanism of the impact of medical insurance cost control policy on the pharmaceutical manufacturing industrial organization? And what is the effect of influence? Is it a positive guide and incentive or a negative hindrance? It is of great practical and theoretical significance to identify the influence mechanism of medical insurance cost control policy on pharmaceutical manufacturing industrial organization and to verify the influence effect of medical insurance cost control policy on pharmaceutical manufacturing industrial organization for the implementation of medical insurance cost control policy and pharmaceutical manufacturing industrial organization.This dissertation constructs a policy evaluation econometric model using panel data of pharmaceutical manufacturing industry from 2015-2020,and highlights the impact of medical insurance cost control policy on pharmaceutical manufacturing industrial organization by comparing the differences before and after the implementation of medical insurance cost control policy from the market structure,behavior,and market performance of pharmaceutical manufacturing industrial organization in turn.It is found that(1)the medical insurance cost control policy has a positive influence on the market structure of pharmaceutical manufacturing industry;(2)the medical insurance cost control policy significantly increases the cost of sales rate of pharmaceutical manufacturing companies and has a significant effect on the marketing strategy of market behavior;(3)in terms of the market performance of pharmaceutical manufacturing industry,it is confirmed that the medical insurance cost control policy has a significant negative effect on the market performance of pharmaceutical manufacturing industry,which is reflected in the reduction of return on assets and sales margin of pharmaceutical manufacturing industry.The conclusions of this dissertation are as follows:(1)The medical insurance cost control policy has a significant effect on the asset size of pharmaceutical manufacturing enterprises,which is a highly capital-intensive industry.Under the guidance of the national policy of " vacating cage to change bird and adjust the structure",pharmaceutical companies are "stronger than ever".Compared with before the implementation,the medical insurance cost control policy has significantly increased the market share and market share of pharmaceutical manufacturing companies.(2)The medical insurance cost control policy has played a good guiding effect on the market behavior of enterprises.The medical insurance cost control policy has prompted pharmaceutical manufacturing enterprises to change their marketing strategies.After the implementation of the policy,the market manipulation by enterprises through monopoly pricing and other market behavior strategies has been effectively controlled,and the government has restricted unreasonable prices through centralized medicine procurement and other measures.(3)The implementation of national medical insurance cost control policy is only one factor affecting market performance,and the impact of industrial organization market structure and market behavior on the market performance of pharmaceutical manufacturing industry is very much worthy of attention.The innovations of this dissertation are mainly the following three points.(1)It reveals the mechanism of the impact of medical insurance cost control policy on the pharmaceutical manufacturing industrial organization.The medical insurance cost control policy has a positive effect on the market structure of the pharmaceutical manufacturing industry.The medical insurance cost control policy has a significant contribution to the asset size of pharmaceutical manufacturing companies,which significantly increases the market share of companies in the pharmaceutical manufacturing industry and improves the market share.The medical insurance cost control policy significantly increases the sales-expense ratio of pharmaceutical manufacturing companies and has a significant effect on the marketing strategy of market behavior.In the section of medical insurance cost control policy and market performance,it is confirmed that medical insurance cost control policy has a significant impact on the market performance of pharmaceutical manufacturing industry.The impact of medical insurance cost control policy is significantly better for chemical pharmaceutical companies involved in mining than for non-chemical pharmaceutical companies.The medical insurance cost control policy has a good guiding and incentive effect on the organization of pharmaceutical manufacturing industry.(2)A government policy-structure-behavior-performance(G-SCP)analysis framework for the impact of policy on industrial organization was constructed.In the past,studies have focused more on the interaction between market structure,market behavior and market performance of pharmaceutical manufacturing industrial organization,but less on the impact of medical insurance cost control policy on pharmaceutical manufacturing industrial organization from a dynamic and macroscopic perspective using the standard industrial organization theory and analysis framework.The article makes full use of the existing SCP paradigm theoretical framework of industrial organization,and constructs a government policy-structure-behavior-performance(G-SCP)analysis framework of the impact of policy on industrial organization by introducing medical insurance cost control policy as an external factor,taking policy as the logical starting point and the impact on market structure,behavior and performance of industrial organization as the logical end point.(3)The impact of medical insurance cost control policy on the industrial organization of pharmaceutical manufacturing was confirmed.The current research on medical insurance cost control policy mainly focuses on the review of policy from the management perspective or the analysis of the impact of policy implementation on disease diagnosis and treatment,drug use and expenditure from the medical perspective,and the research focusing on the impact of medical insurance cost control policy on the pharmaceutical manufacturing industrial organization has not been covered.This dissertation proposes to extend the study of policy impact to pharmaceutical manufacturing industrial organization,and empirically test the impact of medical insurance cost control policy on market structure,market behavior and market performance of pharmaceutical manufacturing industry through policy evaluation econometric model,which provides new empirical evidence on the impact of medical insurance cost control policy and enriches and expands the research on the impact of medical insurance cost control policy on pharmaceutical manufacturing industrial organization. |
PDF Full Text Request